Meeting Abstract


DOI :10.26650/JARHS2021-1136707   IUP :10.26650/JARHS2021-1136707    Full Text (PDF)

DOWNREGULATION OF SLC-16 CAN INCREASE APOPTOSIS LEVEL IN GASTROINTESTINAL CANCER

Milad AsadiDariush ShanehbandıShahriar HashemzadehHabib ZarehdarShahram GhasembaıglouVenus ZafariTuoraj Asvadi KermaniAyşe Caner

Background: Gastrointestinal cancers constitute 35% of all cancer-related deaths and chemotherapy resistance is a major challenge for the treatment of these cancers. The SLC gene family encodes various group of membrane transmitters that play critical roles in establishing cellular homeostasis by transporting ions and different molecular groups. To date, studies have revealed the active roles of some of SLC members in chemotherapy resistance in various malignancies. However, there is no study to investigate the roles of SLC-16 gene in tumor biology. Therefore, we aimed to consider the effects of downregulation of SLC-16 in cell lines related to gastrointestinal cancers. Methods: SCL-16 expression was downregulated in SW-480, KATO-3and PANC-1 cell lines using sh-RNA transfection. RT-PCR and western blot were performed to prove downregulation of SCL-16 knockdown levels in these cell lines. Then, Oxaliplatin was treated to all cells and the effects of this drug were evaluated by cell cycle, apoptosis, and cell migration assays in downregulated SRC cells. Results: SLC-16 was found to be down-regulated after sh-RNA transfection at the mRNA and protein levels. In the downregulated group of SCL-16, it was detected that Oxaliplatin increased apoptosis and cell numbers in the G-1 of the cell cycle but had no effect on the cells’ ability to metastasize. Conclusion: SLC-16, one of the SLC families, plays critical roles in the stabilization of cancer cells, and targeting applications of this gene may be a potential way to enhance the effects of chemotherapy in gastrointestinal cancer.


PDF View

References

    Citations

    Copy and paste a formatted citation or use one of the options to export in your chosen format


    EXPORT



    APA

    Asadi, M., Shanehbandı, D., Hashemzadeh, S., Zarehdar, H., Ghasembaıglou, S., Zafari, V., Asvadi Kermani, T., & Caner, A. (2022). DOWNREGULATION OF SLC-16 CAN INCREASE APOPTOSIS LEVEL IN GASTROINTESTINAL CANCER. Journal of Advanced Research in Health Sciences, 5(1), 39-39. https://doi.org/10.26650/JARHS2021-1136707


    AMA

    Asadi M, Shanehbandı D, Hashemzadeh S, Zarehdar H, Ghasembaıglou S, Zafari V, Asvadi Kermani T, Caner A. DOWNREGULATION OF SLC-16 CAN INCREASE APOPTOSIS LEVEL IN GASTROINTESTINAL CANCER. Journal of Advanced Research in Health Sciences. 2022;5(1):39-39. https://doi.org/10.26650/JARHS2021-1136707


    ABNT

    Asadi, M.; Shanehbandı, D.; Hashemzadeh, S.; Zarehdar, H.; Ghasembaıglou, S.; Zafari, V.; Asvadi Kermani, T.; Caner, A. DOWNREGULATION OF SLC-16 CAN INCREASE APOPTOSIS LEVEL IN GASTROINTESTINAL CANCER. Journal of Advanced Research in Health Sciences, [Publisher Location], v. 5, n. 1, p. 39-39, 2022.


    Chicago: Author-Date Style

    Asadi, Milad, and Dariush Shanehbandı and Shahriar Hashemzadeh and Habib Zarehdar and Shahram Ghasembaıglou and Venus Zafari and Tuoraj Asvadi Kermani and Ayşe Caner. 2022. “DOWNREGULATION OF SLC-16 CAN INCREASE APOPTOSIS LEVEL IN GASTROINTESTINAL CANCER.” Journal of Advanced Research in Health Sciences 5, no. 1: 39-39. https://doi.org/10.26650/JARHS2021-1136707


    Chicago: Humanities Style

    Asadi, Milad, and Dariush Shanehbandı and Shahriar Hashemzadeh and Habib Zarehdar and Shahram Ghasembaıglou and Venus Zafari and Tuoraj Asvadi Kermani and Ayşe Caner. DOWNREGULATION OF SLC-16 CAN INCREASE APOPTOSIS LEVEL IN GASTROINTESTINAL CANCER.” Journal of Advanced Research in Health Sciences 5, no. 1 (Feb. 2024): 39-39. https://doi.org/10.26650/JARHS2021-1136707


    Harvard: Australian Style

    Asadi, M & Shanehbandı, D & Hashemzadeh, S & Zarehdar, H & Ghasembaıglou, S & Zafari, V & Asvadi Kermani, T & Caner, A 2022, 'DOWNREGULATION OF SLC-16 CAN INCREASE APOPTOSIS LEVEL IN GASTROINTESTINAL CANCER', Journal of Advanced Research in Health Sciences, vol. 5, no. 1, pp. 39-39, viewed 24 Feb. 2024, https://doi.org/10.26650/JARHS2021-1136707


    Harvard: Author-Date Style

    Asadi, M. and Shanehbandı, D. and Hashemzadeh, S. and Zarehdar, H. and Ghasembaıglou, S. and Zafari, V. and Asvadi Kermani, T. and Caner, A. (2022) ‘DOWNREGULATION OF SLC-16 CAN INCREASE APOPTOSIS LEVEL IN GASTROINTESTINAL CANCER’, Journal of Advanced Research in Health Sciences, 5(1), pp. 39-39. https://doi.org/10.26650/JARHS2021-1136707 (24 Feb. 2024).


    MLA

    Asadi, Milad, and Dariush Shanehbandı and Shahriar Hashemzadeh and Habib Zarehdar and Shahram Ghasembaıglou and Venus Zafari and Tuoraj Asvadi Kermani and Ayşe Caner. DOWNREGULATION OF SLC-16 CAN INCREASE APOPTOSIS LEVEL IN GASTROINTESTINAL CANCER.” Journal of Advanced Research in Health Sciences, vol. 5, no. 1, 2022, pp. 39-39. [Database Container], https://doi.org/10.26650/JARHS2021-1136707


    Vancouver

    Asadi M, Shanehbandı D, Hashemzadeh S, Zarehdar H, Ghasembaıglou S, Zafari V, Asvadi Kermani T, Caner A. DOWNREGULATION OF SLC-16 CAN INCREASE APOPTOSIS LEVEL IN GASTROINTESTINAL CANCER. Journal of Advanced Research in Health Sciences [Internet]. 24 Feb. 2024 [cited 24 Feb. 2024];5(1):39-39. Available from: https://doi.org/10.26650/JARHS2021-1136707 doi: 10.26650/JARHS2021-1136707


    ISNAD

    Asadi, Milad - Shanehbandı, Dariush - Hashemzadeh, Shahriar - Zarehdar, Habib - Ghasembaıglou, Shahram - Zafari, Venus - Asvadi Kermani, Tuoraj - Caner, Ayşe. DOWNREGULATION OF SLC-16 CAN INCREASE APOPTOSIS LEVEL IN GASTROINTESTINAL CANCER”. Journal of Advanced Research in Health Sciences 5/1 (Feb. 2024): 39-39. https://doi.org/10.26650/JARHS2021-1136707



    TIMELINE


    Published Online09.08.2022

    LICENCE


    Attribution-NonCommercial (CC BY-NC)

    This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


    SHARE




    Istanbul University Press aims to contribute to the dissemination of ever growing scientific knowledge through publication of high quality scientific journals and books in accordance with the international publishing standards and ethics. Istanbul University Press follows an open access, non-commercial, scholarly publishing.